The increasing number of cases for diabetes worldwide is a concern. Therefore, it is of interest to design therapeutic peptides to overcome side effects caused by the available drugs. It should be noted that data on several known anti-diabetic peptides is available in the literature in an organized manner. Hence, it is of interest to collect, glean and store such data in form of a searchable database supported by RDBMS. Data on anti-diabetic peptides and their related data are collected from the literature using manual search. Data on related peptides from other databases (THPdb, ADP3, LAMP, AHTPDB, AVPdb, BioPepDB, CancerPPD, CPPsite, DRAMP, SATPdb, CAMPR3 and MBPDB) are also included after adequate curation. Thus, we describe the development and utility of BioDADPep, a Bioinformatics database for antidiabetic peptides. The database has cross-reference for antidiabetic peptides. The database is enabled with a web-based GUI using a simple Google-like search function. Data presented in BioDADPep finds application in the design of an effective anti-diabetic peptide.
Background:
Diabetes mellitus is a pandemic non-communicable chronic autoimmune disease affecting the quality of life (diet and lifestyle). It is estimated that diabetes mellitus will rise to 592 million by the year 2035 [1] . Approximately 50% of patients with diabetes mellitus are believed to be unaware of their condition [2] . Diabetes Mellitus may go up from ninth to seventh most important reason of death worldwide by 2030 [3] . Based upon the etiology, diabetes mellitus can be divided into two main types, Type 1, "Juvenile Diabetes Mellitus" (Insulin Dependent Diabetes Mellitus) and Type 2, "adult type" (Non-Insulin Dependent Diabetes Mellitus) [4]. Type 1 diabetes (Insulin Dependent Diabetes Mellitus, IDDM or juvenile onset diabetes), occurs when the pancreas do not produce enough insulin due to destruction of pancreatic β-cells mediated by auto reactive T-cells resulting in chronic insulitis [5].
In Type 2, "adult type" (Non-Insulin Dependent Diabetes Mellitus), primary insulin resistance, rather than defective insulin production due to β-cells destruction, seems to be the triggering alteration [6] .
BioDADPep is an online database of published data about Type 1 and Type 2 diabetes mellitus peptides, their targets and other related data. A comprehensive visualization of all known antidiabetic peptides is important for peptide classification, modification and design. It is of interest to design different formulations of peptides for improved half-life, immunogenicity, chemical activity, solubility, side effects, toxicity and others [7] . It is promising to modify the structure to enhance stability, increase the half-life and improve membrane permeability of the peptide after calculating the binding and selectivity using structural features (Figure 1) . This data forms primary data for the database. The source (synthetic or natural) of the peptides is also included in the database. Similar or linked or related peptides from other databases also included in the database. 
Home page:
Homepage give introduction on BioDADPep (Figure 2) .
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BioDADPep Search:
The BioDADPep database has search utility for keywords.
Data statistics:
Data statistics with graphs, figures and facts is made available.
Help:
The HELP page assists to navigate BioDADPep in a step-by-step manner.
